Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 3/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25580255 | 0.96 | HSD17B1 (0.32) | HCRTR1HSD17B1HSD17B2GPR84CYP1A2 | |
| SCHEMBL25580376 | 0.94 | HSD17B1 (0.32) | HSD17B1HSD17B2GPR84ALDH1A1MAPT | |
| SCHEMBL25578967 | 0.94 | HCRTR1 (0.34) | HCRTR1HSD17B1HSD17B2GPR84CYP1A2 | |
| SCHEMBL25580297 | 0.94 | AHR (0.32) | ALDH1A1MAPT | |
| SCHEMBL25580313 | 0.93 | MMP12 (0.33) | HCRTR1ALDH1A1MAPT | |
| SCHEMBL25580749 | 0.92 | HCRTR1 (0.35) | HCRTR1HSD17B1HSD17B2GPR84CYP1A2 | |
| SCHEMBL25581019 | 0.92 | HCRTR1 (0.35) | HCRTR1HSD17B1HSD17B2GPR84CYP1A2 | |
| SCHEMBL24919815 | 0.92 | HCRTR1 (0.37) | HCRTR1HSD17B1HSD17B2GPR84CYP1A2 | |
| SCHEMBL27274205 | 0.92 | HCRTR1 (0.37) | HCRTR1HSD17B1HSD17B2GPR84CYP1A2 | |
| SCHEMBL23225291 | 0.91 | HCRTR1 (0.36) | HCRTR1HSD17B1HSD17B2CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230180597-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | ESR1, L1CAM, ESR2 | HCRTR1 3385/4885HSD17B1 3017/4885HSD17B2 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.